| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEODERIV | May 14 | D | 104,834 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEODERIV | May 14 | D | 131,093 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEODERIV | May 14 | D | 150,000 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEODERIV | May 14 | D | 206,250 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEODERIV | May 14 | D | 170,400 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEODERIV | May 14 | D | 273,312 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEODERIV | May 14 | D | 287,500 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEODERIV | May 14 | D | 273,779 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEODERIV | May 14 | D | 100,538 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | D | 195,952 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | D | 97,997 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | D | 36,047 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | D | 20,862 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | D | 195,952 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | A | 195,952 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | D | 97,976 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | A | 97,976 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | D | 87,108 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | A | 87,108 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | D | 143,750 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | A | 143,750 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | U | 234,411 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | U | 300,000 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | U | 472,065 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | U | 372,815 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | May 14 | U | 425,968 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | Mar 11 | G | 64,869 | $0.00 | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | Mar 11 | G | 64,869 | $0.00 | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEODERIV | Feb 3 | M | 8,840 | $0.00 | —? |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | Feb 3 | M | 8,840 | $3.76 | $33K |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | Jan 28 | A | 195,952 | $0.00 | — |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | Jan 22 | S | 27,192 | $21.77 | $592K |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | Jan 20 | S | 8,182 | $19.79 | $162K |
| Apellis Pharmaceuticals, Inc. | APLS | Cedric FrancoisCEO | Jan 13 | S | 10,186 | $22.19 | $226K |